Obesity and Glucagon-Like Peptide-1 Receptor Agonists

This Viewpoint discusses factors associated with the prevalence of obesity worldwide and whether the novel glucagon-like peptide-1 receptor agonists (GLP-1) can help unlock a health systems response to the obesity pandemic.

Authors

Francesca L. Celletti
Francesco Branca (ORCID: https://orcid.org/0000-0002-4238-1433)
Jeremy Farrar (ORCID: https://orcid.org/0000-0002-2700-623X)

Institutions

World Health Organization (CH)

Publication Details

Journal: JAMA
Published: 2024-12-18
DOI: https://doi.org/10.1001/jama.2024.25872
Citations: 11
Primary Topic: Diabetes Treatment and Management
Type: article
Field-Weighted Citation Impact: 3.93

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Obesity and Glucagon-Like Peptide-1 Receptor Agonists

Francesca L. Celletti, Francesco Branca, Jeremy Farrar

Dec 18, 2024

11 citations

JAMA

Diabetes Treatment and Management

3.93

article

Obesity and Glucagon-Like Peptide-1 Receptor Agonists

Francesca L. Celletti, Francesco Branca, Jeremy Farrar

December 18, 2024article en

11 citations

Abstract

JAMAVol. 333(7)

World Health Organization (CH)

Good health and well-being

Openalex Percentile: Top 5%

Diabetes Treatment and Management

3.93

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Obesity and Glucagon-Like Peptide-1 Receptor Agonists — Francesca L. Celletti, Francesco Branca, et al. · JAMA (2024) | TGRS Research Map | TGRS